Literature DB >> 16732323

Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells.

O Pasder1, S Shpungin, Y Salem, A Makovsky, S Vilchick, S Michaeli, H Malovani, U Nir.   

Abstract

Fer is a nuclear and cytoplasmic intracellular tyrosine kinase. Herein we show that Fer is required for cell-cycle progression in malignant cells. Decreasing the level of Fer using the RNA interference (RNAi) approach impeded the proliferation of prostate and breast carcinoma cells and led to their arrest at the G0/G1 phase. At the molecular level, knockdown of Fer resulted in the activation of the retinoblastoma protein (pRB), and this was reflected by profound hypo-phosphorylation of pRB on both cyclin-dependent kinase CDK4 and CDK2 phosphorylation sites. Dephosphorylation of pRB was not seen upon the direct targeting of either CDK4 or CDK2 expression, and was only partially achieved by the simultaneous depletion of these two kinases. Amino-acid sequence analysis revealed two protein phosphatase 1 (PP1) binding motifs in the kinase domain of Fer and the association of Fer with the pRB phosphatase PP1alpha was verified using co-immunoprecipitation analysis. Downregulation of Fer potentiated the activation of PP1alpha and overexpression of Fer decreased the enzymatic activity of that phosphatase. Our findings portray Fer as a regulator of cell-cycle progression in malignant cells and as a potential target for cancer intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16732323     DOI: 10.1038/sj.onc.1209695

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  High-resolution structural analysis shows how different crystallographic environments can induce alternative modes of binding of a phosphotyrosine peptide to the SH2 domain of Fer tyrosine kinase.

Authors:  Yoshiyuki Matsuura
Journal:  Protein Sci       Date:  2019-08-31       Impact factor: 6.725

Review 2.  Prostate cancer: the need for biomarkers and new therapeutic targets.

Authors:  Juliana Felgueiras; Joana Vieira Silva; Margarida Fardilha
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

3.  Intronic promoter drives the BORIS-regulated expression of FerT in colon carcinoma cells.

Authors:  Adar Makovski; Etai Yaffe; Sally Shpungin; Uri Nir
Journal:  J Biol Chem       Date:  2012-01-05       Impact factor: 5.157

Review 4.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

5.  Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.

Authors:  Masanori Kawakami; Rie Ishikawa; Yosuke Amano; Mitsuhiro Sunohara; Kousuke Watanabe; Nobuya Ohishi; Yutaka Yatomi; Jun Nakajima; Masashi Fukayama; Takahide Nagase; Daiya Takai
Journal:  Cancer Sci       Date:  2013-09-05       Impact factor: 6.716

6.  FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.

Authors:  Masanori Kawakami; Shigeki Morita; Mitsuhiro Sunohara; Yosuke Amano; Rie Ishikawa; Kousuke Watanabe; Emi Hamano; Nobuya Ohishi; Jun Nakajima; Yutaka Yatomi; Takahide Nagase; Masashi Fukayama; Daiya Takai
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

7.  Fer kinase regulates cell migration through α-dystroglycan glycosylation.

Authors:  Tohru Yoneyama; Kiyohiko Angata; Xingfeng Bao; Sara Courtneidge; Sumit K Chanda; Minoru Fukuda
Journal:  Mol Biol Cell       Date:  2012-01-11       Impact factor: 4.138

8.  Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells.

Authors:  Haiyu Li; Zhenggang Ren; Xiaonan Kang; Lan Zhang; Xuefei Li; Yan Wang; Tongchun Xue; Yuefang Shen; Yinkun Liu
Journal:  BMC Cancer       Date:  2009-10-16       Impact factor: 4.430

9.  High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma.

Authors:  Can Wei; Song Wu; Xianxin Li; Yadong Wang; Rui Ren; Yongqing Lai; Jiongxian Ye
Journal:  Oncol Lett       Date:  2012-11-16       Impact factor: 2.967

10.  FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance.

Authors:  I A Ivanova; J F Vermeulen; C Ercan; J M Houthuijzen; F A Saig; E J Vlug; E van der Wall; P J van Diest; M Vooijs; P W B Derksen
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.